Sex differences in response to citalopram: a STAR*D report. - Wikidata - awgldk - TriplyDB

Sex differences in response to citalopram: a STAR*D report.

Sex differences in response to citalopram: a STAR*D report.

http://www.wikidata.org/entity/Q37190644

about

Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?A genomewide association study of citalopram response in major depressive disorder Obesity and Its Potential Effects on Antidepressant Treatment Outcomes in Patients with Depressive Disorders: A Literature Review Effects of sex and gender on adaptation to space: behavioral health Levomilnacipran for the treatment of major depressive disorder: a review Sex differences in stress-induced social withdrawal: role of brain derived neurotrophic factor in the bed nucleus of the stria terminalis.Sex-specific antidepressant effects of dietary creatine with and without sub-acute fluoxetine in rats Inclusion of women and gender-specific analyses in randomized clinical trials of treatments for depression.The FDA And ABCs: Unintended Consequences Of Antidepressant Warnings On Human Capital.Association between a serotonin transporter promoter polymorphism (5HTTLPR) and personality disorder traits in a community sample.Raphe-Hippocampal Serotonin Neurotransmission In The Sex Related Differences of Adaptation to Stress: Focus on Serotonin-1A Receptor.Studying both sexes: a guiding principle for biomedicine.Sampling bias in an internet treatment trial for depression.Prozac during puberty: distinctive effects on neurogenesis as a function of age and sex.Serotonin and arginine-vasopressin mediate sex differences in the regulation of dominance and aggression by the social brain Sex differences in the psychopharmacological treatment of depression.A gender analysis of the study of pharmacotherapy of psychotic depression (STOP-PD): gender and age as predictors of response and treatment-associated changes in body mass index and metabolic measures Sex differences in the prediction of the effectiveness of paroxetine for patients with major depressive disorder identified using a receiver operating characteristic curve analysis for early response.Genetic variability in estrogen disposition: Potential clinical implications for neuropsychiatric disorders.Gender differences in depression.Modeling depression in adult female cynomolgus monkeys (Macaca fascicularis).Pharmacokinetics and pharmacodynamics of psychotropic drugs: effect of sex.Sex differences in the pharmacokinetics of antidepressants: influence of female sex hormones and oral contraceptives.Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines.An observational study of duloxetine versus SSRI monotherapy in Japanese patients with major depressive disorder: subgroup analyses of treatment effectiveness for pain, depressive symptoms, and quality of life.Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks.Preclinical sex differences in depression and antidepressant response: Implications for clinical research.Sex, hormones, and genotype interact to influence psychiatric disease, treatment, and behavioral research.Changes in depression subtypes for women during treatment with citalopram: a latent transition analysis.Changes in Depression Subtypes Among Men in STAR*D: A Latent Transition Analysis.Sex Differences in Effects of Ketamine on Behavior, Spine Density, and Synaptic Proteins in Socially Isolated Rats.Predictive socioeconomic and clinical profiles of antidepressant response and remission.Predictors of 12-week remission in a nationwide cohort of people with depressive disorders: the CRESCEND study.Influence of gender and menopausal status on antidepressant treatment response in depressed inpatients.Locomotor sensitization to intermittent ketamine administration is associated with nucleus accumbens plasticity in male and female rats.Pharmacotherapy for social anxiety disorder: Interpersonal predictors of outcome and the mediating role of the working alliance.Sex-specific transcriptional signatures in human depression.Computational Model of Antidepressant Response Heterogeneity as Multi-pathway Neuroadaptation.Serotoninergic effects on judgments and social learning of trustworthiness.Alterations of the Human Skin N- and O-Glycome in Basal Cell Carcinoma and Squamous Cell Carcinoma.

P2860

Q24631151-BC9207FD-83CF-47ED-9F46-4AEE8AE430B2 Q24656746-3ACAF30A-5FB8-456F-B7FE-FA44E18FDC3E Q26771735-8EA599B5-3533-46A2-B1F9-A417543A1B91 Q26824470-DF86BC57-846B-406C-AAD8-8ABC5CD470CC Q28083216-F7CDB691-9930-49F9-9D8E-A81542F0E81D Q30444597-F64B30D2-1306-47D7-9200-304ACA100631 Q33771249-F820C3B6-5748-4BB6-BF2A-20505CB32189 Q34115025-16A69465-3AC9-471E-A8E3-0194CE5E1094 Q34275043-0C6AF34C-EE33-43F5-A430-DCC035407B61 Q35083877-D92A42DA-76CD-4DFA-81C3-B7EC2437A017 Q35151893-C03BB267-5A76-4844-B3C5-DA36214CA984 Q36466980-8F4A89DE-B2B9-45DF-BB51-709A4129DB89 Q36591347-D3A20030-239A-434F-A215-C113F01A3E06 Q37338773-3B773DF5-EB50-42B1-9F11-6122FCCB2DE7 Q37469550-A8D22D76-FBD2-43A4-81AC-EC7EE534E843 Q37618539-B94CAD5F-2A7A-4840-8266-E327880DE7B3 Q37663969-0B79AC5C-3CF9-46BD-9669-1EA6EA33AE39 Q37702179-731F9B2C-5D2D-4318-80AD-5A569CF28844 Q37795699-5C8CF0ED-4F83-4403-A486-D92A82F15900 Q37806752-DE0D095B-FBC1-4A66-9C95-E9CCA2C0C8D2 Q37955135-0473CEAD-FBAE-4FAF-A455-1E0F768D1199 Q38078561-D33E4C2B-ECD6-4209-A370-644B80D15209 Q38214488-7DB44495-86C5-457F-A2EF-D213B5F93B0D Q38476909-6967B4E9-EBAB-4E82-B95C-4497201D19F3 Q38613235-AD0B8F49-3E92-4E7F-849E-6603DD8A1D78 Q38657429-82D9C27E-805A-469C-AD7C-9B5A7797D7A8 Q38792679-06649845-B03F-492E-B2BB-D602AD98BA71 Q39015400-7797B1BC-A02E-4CAF-86B0-DF9AC5644334 Q40071013-72A4C71A-55BE-4E03-B19D-122423910B8F Q40464740-2029A57B-C27D-43FD-BEAB-F0DFEC7492D5 Q41729285-E05CB4CA-F913-4309-934D-F7A78EE817DB Q44209591-66AF6803-45E2-42BA-AD66-C8394F6C511C Q45737305-C2439738-B02A-4D1A-B053-4AFDAEE6663C Q46021208-D3EE9C56-BF10-4596-97D6-3F57D2720468 Q47299450-D01C1BDC-08A9-41EC-BC3D-CCBF92360D5A Q47627715-7A7C26AD-0652-42BE-8A5D-65BBB09C908B Q47641958-65FFD945-1F00-4B23-A196-A284F5869EDD Q47644422-05A8C09E-BFBE-40EE-BB95-C4A830EAA8F1 Q48364109-42666179-334B-493A-82F5-2EB92C8EB10E Q52331518-06C58846-AAA3-452D-B027-34DBD7BEBBBD

P2860

Sex differences in response to citalopram: a STAR*D report.

http://www.wikidata.org/entity/Q37190644

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 August 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Sex differences in response to citalopram: a STAR*D report.

@en

Sex differences in response to citalopram: a STAR*D report.

@nl

type

label

Sex differences in response to citalopram: a STAR*D report.

@en

Sex differences in response to citalopram: a STAR*D report.

@nl

prefLabel

Sex differences in response to citalopram: a STAR*D report.

@en

Sex differences in response to citalopram: a STAR*D report.

@nl

P1433

Q37190644-5DC9DF2C-0056-46BC-949D-4002844F65AE

P1476

Q37190644-B252E30E-CD45-4FD3-B0EC-A5B43DFF6170

P2093

Q37190644-02A98859-AACA-4D30-933A-6509790A98D3

Q37190644-0FC98389-4B81-4923-B574-F25DD4F4415C

Q37190644-2D630847-55DE-42AE-8DD3-56DCA60EB52E

Q37190644-37DFAAB0-2F4A-4B5A-87BA-8B778CEE1619

Q37190644-4B47C49D-B3E2-447B-804D-7D05FE1BF1CD

Q37190644-548F5509-F3E3-4D55-B4E9-8CB2FD58B529

Q37190644-61F47DE6-9E36-41A8-A404-EC42F0DF0132

Q37190644-7D443DB5-9ACD-4D08-9C3D-435DA93C976A

Q37190644-958B0887-6053-44BF-B180-49E5DD7F07EA

P2860

Q37190644-05355FC2-E138-4B66-B92E-B9C266744883

Q37190644-0FAFD6E5-2E75-40B0-A05C-4141A54C1AB6

Q37190644-251985E1-F003-4C71-B6D1-44427873FAEF

Q37190644-271F0673-5C33-4CD4-8342-7F6C74051796

Q37190644-2ACB0FD2-9251-42D1-B08B-94E03BAE2C7D

Q37190644-2E2541A7-B29F-4E05-A1F6-3EDBB479A3A5

Q37190644-33E41631-77F5-4DA9-9CCD-2477B0CC63E1

Q37190644-3727D4BE-F6CE-4A1E-8165-38633E827A0B

Q37190644-385B0379-4678-4A6A-8DD0-C6FC74B34791

Q37190644-3A7336A5-67FD-47AF-A9F1-B1EFDA7F29DA

P304

Q37190644-94EEBD99-BEF3-4460-B777-4672F41C7660

P31

Q37190644-7E6B4554-A47A-45A6-9B75-92B5DE30A7CB

P356

Q37190644-66D5B883-70CE-4834-A75A-5D6FA273F9B6

P433

Q37190644-36D732FD-A497-464E-B594-7A9B14149BCD

P478

Q37190644-09A32627-B86D-4CB5-AA1A-4A8D132844CA

P50

Q37190644-FD35D376-9EA9-4127-823E-AC93A30DD383

P577

Q37190644-49F2E650-2255-4AE1-A427-26B7F65DD481

P5875

Q37190644-6B740F92-4F2D-4F32-9B9A-A32D2169D653

P698

Q37190644-D73D052B-4BC4-48F5-B99B-951779F884EC

P932

Q37190644-133CE900-06C4-4563-A8CD-318C2AE67898

P356

J.JPSYCHIRES.2008.07.002

P1433

Journal of Psychiatric Research

P1476

Sex differences in response to citalopram: a STAR*D report.

@en

P2093

A John Rush

http://www.w3.org/2001/XMLSchema#string

Anne T Harvey

http://www.w3.org/2001/XMLSchema#string

Diane Warden

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Young

http://www.w3.org/2001/XMLSchema#string

G K Balasubramani

http://www.w3.org/2001/XMLSchema#string

Madhukar H Trivedi

http://www.w3.org/2001/XMLSchema#string

Maurizio Fava

http://www.w3.org/2001/XMLSchema#string

Sheila M Marcus

http://www.w3.org/2001/XMLSchema#string

Susan G Kornstein

http://www.w3.org/2001/XMLSchema#string

P2860

A rating scale for depression

The MOS 36-ltem Short-Form Health Survey (SF-36)

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

No gender differences in placebo responses of patients with major depressive disorder.

Cumulative illness rating scale.

Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.

Diverse actions of ovarian steroids in the serotonin neural system.

Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report.

Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.

P304

503-511

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JPSYCHIRES.2008.07.002

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P50

Stephen R. Wisniewski

P577

2008-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23219423

http://www.w3.org/2001/XMLSchema#string

P698

18752809

http://www.w3.org/2001/XMLSchema#string

P932

2681489

http://www.w3.org/2001/XMLSchema#string